This plan amendment updates the rate year 2024 reimbursement for privately-owned inpatient psychiatric hospital services. Specifically, it establishes a reimbursement methodology for certain long-acting injectable (LAI) antipsychotic pharmaceuticals covered by MassHealth in addition to the psychiatric per diem rate.